Nadim Ahmed has over 25 years of leadership experience in oncology development and commercialization. In his current role as CEO of Cullinan Therapeutics, Nadim oversees an expert team focused on creating new standards of care for patients with cancer and autoimmune diseases through a modality-agnostic, targeted approach. He champions making critical evaluations early in the development process — ensuring only highly differentiated, first- or best-in-class molecules progress.
Nadim has worked with various treatment modalities, including small molecules, biologics and cell therapy. He holds a Master of Science degree from Loughborough University, UK and a Bachelor of Science degree from University College London, UK.
This is not just about the science — it is about the leadership that enables it to reach the people who need it most. With the right leadership and a commitment to bold, thoughtful action, the biotech industry is poised to deliver breakthroughs that will transform lives.
During my 25 years in oncologic drug discovery, development and commercialization, I have seen how economic cycles can skew priorities and slow progress – but we cannot let that happen.
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.